Hemady® is a prescription steroid medication called dexamethasone (deks-a-METH-a-sone) that comes in an oral tablet. It is prescribed along with other medicines to treat adults with multiple myeloma.
Hemady® is tailored to provide the most suitable strength of dexamethasone for use in multiple myeloma.
Before Hemady®, it would take ten of the 4 mg dexamethasone tablets to equal a 40 mg dose. This is because generic oral dexamethasone is available in lower tablet strengths only (i.e., 0.5, 0.75, 1, 1.5, 2, 4, and 6 mg tablets).2 With Hemady®, it only takes two of the 20 mg tablets to reach a 40 mg dose of dexamethasone.3
(lenalidomide)
(bortezomib)
(pomalidomide)
(daratumumab)
(elotuzumab)
(thalidomide)
(selinexor)
(daratumumab-hyaluronidase-fihj)
(isatuximab-irfc)
(ixazomib)
(carfilzomib)
Products approved for combination use in adults with multiple myeloma. Updated August 2023.
Trademarks are properties of respective owners.
Edenbridge Pharmaceuticals, LLC is not affiliated with the manufacturers of any of these products.
If you are taking 20-40 mg of dexamethasone as a part of your multiple myeloma treatment plan, Hemady® may be right for you.1,3
Hemady® (dexamethasone) is believed to have anti-myeloma effects on the cells responsible for causing cancer in multiple myeloma, called myeloma cells. It has been shown that dexamethasone can slow down unwanted myeloma cell growth and cause myeloma cell death. The way in which Hemady® works in treating multiple myeloma is not fully understood, but its safety and effectiveness with other anti-myeloma treatments is well known.1,2
Take dexamethasone only as prescribed by your doctor.
Do not take Hemady® if you:
Your doctor will tell you how to take Hemady® based on the treatment regimen in the other anti-myeloma product prescribed for you.
Hemady® can cause serious side effects including:
Alterations in endocrine function (hormones). This is especially important in patients with diabetes as Hemady® can cause blood glucose levels to rise. Your healthcare provider may monitor glucose levels more frequently. If you have diabetes, talk to your healthcare provider as adjustments in your diabetes medications may be needed.
An increased risk of infection. Hemady® can suppress your immune system. Tell your healthcare provider if you have had any recent or ongoing infections and if you develop any sign of infection while taking Hemady®. Avoid live or live attenuated vaccines.
An increase in blood pressure, salt and water retention, and potassium and calcium excretion. Speak to your healthcare provider to discuss monitoring blood pressure and identifying signs of fluid retention and loss of potassium, especially if you have congestive heart failure, a recent heart attack, or hypertension.
Blood clots in your arteries, veins, and lungs, heart attack, and stroke can happen if you take Hemady® and the risk may be greater when taking Hemady® with other anti-myeloma drugs. Your doctor may prescribe a blood thinner medicine to help prevent clots.
Hemady® may cause cataracts or glaucoma. Your healthcare provider may monitor you for these effects.
Increase the risk of developing gastrointestinal perforation. Promptly seek medical attention if you develop unusually severe, persistent or worsening abdominal pain.
Prolonged use of Hemady® can cause osteoporosis, which can lead to bone fractures.
Unexplained muscle pain, tenderness, or weakness. If you experience these effects, contact your healthcare provider, it may be a condition known as myopathy.
Irritability, mood swings, personality changes, and severe depression. Hemady® can also cause insomnia. Inform your healthcare provider if you notice behavioral and mood changes or have experienced difficulty sleeping.
Risk of Kaposi’s sarcoma. Corticosteroids can cause Kaposi’s sarcoma. Stop taking Hemady® if Kaposi’s sarcoma is diagnosed.
Adverse reactions can occur when Hemady® is taken in combination with anti-myeloma products.
Certain medications can cause an interaction with Hemady®. Tell your doctor about all the medicines you are taking, including over-the-counter medicines, dietary supplements, and herbal products.
Corticosteroids, including Hemady®, can cause fetal harm. Women should not become pregnant while taking Hemady® and for one month after stopping Hemady®. Talk to your healthcare provider if you are pregnant or are planning to become pregnant. Women should not breastfeed while taking Hemady® and for two weeks after the last dose.
These are not all the possible side effects of Hemady®. Call your Healthcare Provider for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088 (1-800-332-1088). You also may contact Edenbridge Pharmaceuticals, LLC at 877-381-3336.
Please see Full Prescribing Information for Hemady®.
Hemady® [Prescribing Information]. Edenbridge Pharmaceuticals, LLC. June 2024.
Information provided on this website is not a substitute for talking with your doctor.
Your doctor is the best source of information about your disease.
All individuals depicted are models used for illustrative purposes only.
Do not take Hemady® if you:
Your doctor will tell you how to take Hemady® based on the treatment regimen in the other anti-myeloma product prescribed for you.
Hemady® can cause serious side effects including:
Alterations in endocrine function (hormones). This is especially important in patients with diabetes as Hemady® can cause blood glucose levels to rise. Your healthcare provider may monitor glucose levels more frequently. If you have diabetes, talk to your healthcare provider as adjustments in your diabetes medications may be needed.
An increased risk of infection. Hemady® can suppress your immune system. Tell your healthcare provider if you have had any recent or ongoing infections and if you develop any sign of infection while taking Hemady®. Avoid live or live attenuated vaccines.
An increase in blood pressure, salt and water retention, and potassium and calcium excretion. Speak to your healthcare provider to discuss monitoring blood pressure and identifying signs of fluid retention and loss of potassium, especially if you have congestive heart failure, a recent heart attack, or hypertension.
Blood clots in your arteries, veins, and lungs, heart attack, and stroke can happen if you take Hemady® and the risk may be greater when taking Hemady® with other anti-myeloma drugs. Your doctor may prescribe a blood thinner medicine to help prevent clots.
Hemady® may cause cataracts or glaucoma. Your healthcare provider may monitor you for these effects.
Increase the risk of developing gastrointestinal perforation. Promptly seek medical attention if you develop unusually severe, persistent or worsening abdominal pain.
Prolonged use of Hemady® can cause osteoporosis, which can lead to bone fractures.
Unexplained muscle pain, tenderness, or weakness. If you experience these effects, contact your healthcare provider, it may be a condition known as myopathy.
Irritability, mood swings, personality changes, and severe depression. Hemady® can also cause insomnia. Inform your healthcare provider if you notice behavioral and mood changes or have experienced difficulty sleeping.
Risk of Kaposi’s sarcoma. Corticosteroids can cause Kaposi’s sarcoma. Stop taking Hemady® if Kaposi’s sarcoma is diagnosed.
Adverse reactions can occur when Hemady® is taken in combination with anti-myeloma products.
Certain medications can cause an interaction with Hemady®. Tell your doctor about all the medicines you are taking, including over-the-counter medicines, dietary supplements, and herbal products.
Corticosteroids, including Hemady®, can cause fetal harm. Women should not become pregnant while taking Hemady® and for one month after stopping Hemady®. Talk to your healthcare provider if you are pregnant or are planning to become pregnant. Women should not breastfeed while taking Hemady® and for two weeks after the last dose.
These are not all the possible side effects of Hemady®. Call your Healthcare Provider for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088 (1-800-332-1088). You also may contact Edenbridge Pharmaceuticals, LLC at 877-381-3336.
Please see Full Prescribing Information for Hemady®.
Hemady® [Prescribing Information]. Edenbridge Pharmaceuticals, LLC. June 2024.
Information provided on this website is not a substitute for talking with your doctor.
Your doctor is the best source of information about your disease.
All individuals depicted are models used for illustrative purposes only.